JUNE 7-9, 2017 • SAN FRANCISCO

ADVANCE PROGRAM

Reasearch & Manufacturing of Probiotics since 1990

Platinum sponsors

Diamond sponsors

BROUGHT TO YOU BY

Gold sponsors

2 IPA WORLD CONGRESS + PROBIOTA AMERICAS

For the second year Probiota Americas and the International ProbioticsAssociation (IPA) unite to create a high-energy event that will fuel growth andinnovation right across the industry. Leaders and innovators from the Americasand the IPA’s global membership will come together to discuss the challengesand opportunities of today’s evolving marketplace, and to find new ways totranslate scientific discoveries into pioneering products that today’s consumerswant to buy.

An interactive conference agenda: presenters and speakers drawn from leadingacademic institutions and businesses share insights, knowledge and practicalexperience. Through roundtables, workshops, debates and discussions you canget involved and make your voice heard.

Peer-to-peer networking: across the three-day program, our informal socialnetworking events encourage the exchange of ideas and the development ofnew relationships across the academic, science and business communities.

“Partnership with Probiota meansinvolvement in the industry’spremier event series and theopportunity to host a bigger andbetter World Congress in marketsboth mature and emerging.”

George Paraskevakos, ExecutiveDirector, IPA

“Our collaboration with IPA putsProbiota at the heart of theindustry and helps us deliver aprogram that responds directly toa growing commercial innovationagenda.”

Margarete Baltay, Event Director

The must attend event for the pre and probiotics industry

across the Americas.

“An extremely useful update from experts in the field and a great chance to meet and mingle.”Kevin Prudence, Managing Director, DSM

“An excellent opportunity to catch up with recent developments in the field.”Mirjana Curic-Bawden, Principal Scientist, Chr. Hansen

“A perfect and much needed connection between science and industry.”Dr Susan Hewlings, Professor, Central Michigan University

Applause!

In 2016 the combined IPA World Congress and Probiota Americas was our biggest ever meeting of experts,welcoming more than 270 participants from across the pre and probiotics industry. Here’s what they said…

93

90

% of attendeesrated the eventexcellent or good

94% said it added value to theirorganization

% agreed itsuccessfully connectsbusiness and science

Maximize knowledge sharing and networking• Start with a deep dive into a specialist area with global experts at one of our First Focus workshops

• Get to the heart of the event with our welcome reception and poster session

• Enjoy a conference agenda focused on the latest analytical tools, scientific research and regulatory

development affecting the industry

• Go for more in-depth analysis with industry expert at our roundtable lunch discussions

• Experience extended networking opportunities and get access to the people you most want to meet

3IPA WORLD CONGRESS + PROBIOTA AMERICAS

Scientific Frontiers sessions – a showcase

of leading edge science

We’re committed to bringing innovative, ground-breaking research toyour attention. In the run up to the event we’ve invited researchers tosubmit abstracts of their most innovative and insightful projects.

All abstracts will be reviewed by our Scientific Committee, leading expertsin the fields of pre and probiotics. Their selection of the best will beinvited to take part in our Scientific Frontiers poster session on the firstevening, or to be presented as a talk on day three of the program.

Agenda

Wednesday June 7Afternoon

1.30 pm Registration

2.00 pm First Focus

workshops

5.30 pm Opening keynote

Evening

6.30 pm Welcome

reception

7.30 pm Day 1 ends

Thursday June 8Morning

8.30 am Plenary

conference

12.30 pm Lunch with

roundtable

discussions

Afternoon

2.00 pm Plenary

conference

Evening

6.30 pm Harbour Cruise

and dinner

Friday June 9Morning

8.45 am Plenary

conference

1.00 pm Networking

lunch

Afternoon

2.30 pm Departures

A powerful partnershipThe International Probiotics Association andProbiota joined forces in 2016 to createexceptional events that bring global insights tothe global probiotics market.

Members benefit from a 25% registrationdiscount. Get the promo code from the IPAand enter when you register online.

Scientific Committee

Dr Joe Alcock, Associate Professor ofEmergency Medicine, University of NewMexico

Dr Michael Cabana, Professor ofPediatrics, Epidemiology andBiostatistics, UCSF

Dr Paul Forsythe, Assistant Professorand Principal Investigator at theMcMaster Brain-Body Institute

Gun-Britt Fransson, VP R&D, Probi

Dr Susan Mitmesser, Director NutritionResearch, NBTY

Dr Deshanie Rai, Senior AssociateDirector, Bayer HealthCare

Dr Mary Ellen Sanders, Consultant,Dairy & Food Culture Technologies

Dr David Sela, Assistant Professor,Department of Food Science, Universityof Massachusetts Amherst

Dr Thomas Tompkins, ResearchDirector, Lallemand Health Solutions

Dr Saskia van Hemert, Senior Scientist,Winclove Probiotics

We’re still accepting abstracts for these sessions. For more informationplease visit www.probiotaamericas.com/abstracts or emailgemma.pearce@wrbm.com

4 IPA WORLD CONGRESS + PROBIOTA AMERICAS

1.30 pm Registration

AGENDADay 1: Wednesday June 7

Prebiotics From early life nutrition to weight management and bone health, we explore latest

developments in prebiotic research, new prebiotic ingredients and their impact on health.

Speakers to be announced

Chaired by: Hank Schultz, Senior Correspondent,NutraIngredients-USA

Chaired by: Dr Stephen Daniells,Senior Editor,NutraIngredients-USA

2.00 pm First Focus workshopsChoose between:

Gut-brain axis The gut-brain axis – the bi-directional interactions between the central nervous system, the

enteric nervous system and the gastro-intestinal tract – is at the cutting edge of current

probiotics research. We explore data from pre-clinical and clinical studies supporting the role

of the microbiome and probiotics in a range of conditions, from general brain function to

depression and anxiety.

Speakers to be announced

5.00 pm Refreshments

7.30 pm End of day 1

5.30 pm Ghosts of our African gutsJeff Leach, Human Food Project & King’s College, London

Mounting research suggests that westerners harbor a less diverse distal gut microbiota than rural

and hunter-gatherer populations. Ongoing research among the hunter-gatherers in Tanzania sug-

gest that while modern diet and lifestyle choices in the industrialized world are ratcheting down

microbial diversity among these populations, it’s the destruction of regional (microbial) species

pool that may be playing a bigger role in human health than previously expected. When consid-

ered against studies like the American Gut project, managing environmental filters may be an

opportunity to reposition our global conversation about prebiotics and probiotics and provide an

on-ramp for a new generation of micro-environmentalist.

• Please pass the microbes

• Do men and women need the same pre- and probiotics? A view from the African savannah

• Eat more fiber or eat more fiber from more sources – which matters more?

6.30 pm Welcome reception and Scientific Frontiers poster session

The Scientific Frontiers poster session presents the latest state-of-the-art developments in all

aspects of prebiotic, probiotic and microbiome science relevant to health, wellbeing, consumers

and industry. Posters will be selected based on abstracts submitted and reviewed by our

Scientific Committee.

Jeff Leach

Jeff is the Founder ofthe Human FoodProject and co-founderof America Gut, theworld’s largest, open-sourcemicrobiome project. He has spent thelast few years living and working amongvarious groups in Africa characterizingthe microbiome of rural and hunter-gatherer groups that “might” hold theclues to the ecological disaster known asthe modern human gut. Jeff is a VisitingResearch Fellow within the Departmentof Twin Research & GeneticEpidemiology at King’s College London.

AGENDA

5IPA WORLD CONGRESS + PROBIOTA AMERICAS

Day 2: Thursday June 8

Welcome from the IPAGeorge Paraskevakos, Executive Director, International Probiotics Association

Welcome from the Chair and scene settingDr Stephen Daniells, Senior Editor, NutraIngredients-USA

As Senior Editor of the market leading NutraIngredients-USA.com and FoodNavigator-USA.com,

Stephen is focused on food and nutrition science reporting at the highest level. He has been

with William Reed for nine years as a senior journalist and editor and is also Editorial Consultant

for WRBM’s Vision Events series. He is a regular speaker at food and nutrition industry

conferences, has a PhD in Chemistry from Queen’s University Belfast and a Certificate in

American Business Practice from North Central College, Naperville, Illinois.

Trends, innovations and opportunities driving the global probioticsmarketMatt Oster, Consumer Health Industry Manager, Euromonitor

The probiotics market is growing and probiotic supplements continue to outperform globalsupplement growth, with an increasing range of applications. Moving beyond digestive health,probiotics are proving to be one of the most versatile ingredients. With such diverse beneficialapplications and a multitude of options for product consumption, market possibilities forprobiotics seem endless. In this presentation, Matthew will give an overview of probiotic trendsshaping the market, with a focus on new insight on probiotic milk, to provide an understandingof the global probiotic landscape and where it is headed.

• Learn about trends, opportunities and challenges shaping the global probiotics market• Gain insight on the marketing of probiotics in food and supplements • Understand where the global probiotics market is headed

David Keller

David began withGaneden as aconsultant in 2003 andhas been with thecompany for more than 14years. He oversees all aspects of clinicaland lab studies, including site selection,protocol design and analysis aftercompletion. To date, 25 clinical trials andreview papers have been published.David was able to obtain FDA GRAS(Generally Regarded as Safe) certificationfor Ganeden’s patented strain ofprobiotic bacteria, GanedenBC30™(Bacillus coagulans GBI-30, 6086) for bothfoods and infant formula, and authoredthe first probiotic specific USPmonograph. David chaired the workinggroup for these guidelines.

IPA/CRN best practices guideline for probiotics Dr David Keller, Vice President of Scientific Operations, Ganeden and Chair of IPA workinggroup on best practices guidelines

As challenges to the food industry continue to arise from both regulatory and consumer groups,the International Probiotics Association (IPA) and Council for Responsible Nutrition joined forcesto create a proactive best practices guideline for probiotics. This voluntary guideline coversboth dietary supplements and functional foods. The goal is to increase transparency to allow allparties to better understand what is contained and being sold in probiotic products. In addition,the IPA has filed a citizens’ petition with the Office of Dietary Supplement Products, formallyrequesting that the unit of measure for probiotics should be changed from milligram to colonyforming units.

• How to label probiotic products • Considerations for stability testing • Considerations for storage recommendations

Matt Oster

Matt overseesEuromonitor’s researchand analysis of in thehealth industryand leadsa team of experts in 80markets worldwide. He was previoulslyHead of Institutional Channels, where heanalyzed the changing global healthcarelandscape and its effects on the B2Bmarketplace for goods and services. Hehas worked in market research since2011, including within the EuromonitorConsumer Health system and holds amaster’s degree from the Johns HopkinsSchool of Advanced InternationalStudies.

George Paraskevakos

Stephen Daniells

Peter Turnbaugh

Peter has worked onthe gut microbiome forthe past 13 years,starting with his graduatestudies in Jeffrey Gordon’slab at Washington University in SaintLouis. From 2010 to 2014 he was a BauerFellow in the FAS Center for SystemsBiology at Harvard University, where heestablished an independent researchgroup prior to starting his faculty positionat UCSF. Notable honors include theKipnis Award in Biomedical Sciences, theNeedleman Pharmacology Prize, theDamon Runyon-Rachleff InnovationAward, and the Searle Scholars Award.He also serves on the Scientific AdvisoryBoard for Seres Therapeutics andWholeBiome.

Food, drugs, and bugs: The role of the gut microbiome in nutrition andpharmacology Dr Peter Turnbaugh, Department of Microbiology & Immunology, University of California, San Francisco

One of the most important limitations to modern medicine is the variation between patients intheir response to dietary and therapeutic interventions. Mutations in the human genome, inparticular the enzymes and transporters expressed in the intestine and liver, have a major impacton drug levels in circulation. But these studies ignore our ‘second genome’ – that of the trillionsof microorganisms that thrive in and on the human body (the microbiome). The Turnbaugh laband colleagues are pursuing a more comprehensive view of pharmacology that includes thestructure and activity of our resident microbial communities and a deeper understanding of theirinteractions with each other, with their host habitat, and with the nutritional milieu of thegastrointestinal tract. Peter’s lecture will include a detailed discussion of the following key areas:

• Humans are home to trillions of microbes that shape host health and disease• Metagenomics (culture-independent methods for microbial ecology) and gnotobiotics (germ-

free and intentionally-colonized mice) provide a powerful approach to understand host-microbiome interactions

• Gut bacteria influence the treatment of human disease by directly metabolizing therapeutics and through their interactions with host tissues

• The gut microbiome is a useful source for novel pre- and pro-biotics or even medications

AGENDA

6 IPA WORLD CONGRESS + PROBIOTA AMERICAS

Regulatory panel discussion

Experts will discuss a range of important regulatory issues, from new dietary ingredients and theestablishment of the ‘grandfathered list of ingredients’, to proposed changes in how naturalproducts are regulated in Canada.

Panelists:• Solange Henoud, Regulatory Affairs Director, Lallemand Health Solutions and Chair of the

IPA’s Regulatory Affairs Committee • Ivan Wasserman, Partner, Amin Talati Upadhye

Further panelists to be announced

Day 2: Thursday June 8

Solange Henoud

Ivan Wasserman

Extended networking and poster viewingTake time to meet your fellow participants and build your network, this is your opportunity tomake new contacts and investigate areas of mutual interest. Or take this chance to view theScientific Frontiers posters.

12:30 pm Lunch with roundtable discussions

Discuss the issues that matter most to you. Tables will be hosted by an expert from industry or academiawho will lead an informal discussion on an industry hot topic. Join the table that suits you best (subject toavailability).

7IPA WORLD CONGRESS + PROBIOTA AMERICAS

AGENDADay 2: Thursday June 8

Keith Barrington

Keith completed hismedical training at theUniversity of Liverpool inthe UK before moving toCanada to take up aneonatal fellowship in Edmonton Albertain 2008. Since then he has held severaluniversity posts and has served as Chairof the Fetus and Newborn Committee ofthe Canadian Pediatric Society and of theSociety of Neonatologists of Quebec.His research interests include apnea andrespiratory control, cardiovascularadaptations and circulatory support, andethical decision making. He has recentlybeen investigating the development ofthe neonatal microbiome and the role ofprobiotics in preventing serious intestinaldiseases. He has published extensively,is an active member of the Neonatalreview group of the Cochranecollaboration and a busy blogger atneonatalresearch.org.

Manipulating the microbiome in micro-premature babies Dr Keith Barrington, Neonatologist and clinical researcher, Sainte Justine University HealthCenter, and Professor of Pediatrics, University of Montreal

When babies are born prematurely the normal colonization of their intestines is deranged. Thisleads to serious complications, including infections and necrotizing enterocolitis. Routinesupplementation with probiotics has been proven to reduce these serious and life-threateningcomplications. Based on clinical experience and recent research, Keith will explain:

• Cause and effect – how premature babies are affected by their abnormal intestinal mircobiomes and how they can be treated with probiotics

• Lessons learned – experiences with the routine use of probiotics in a Canadian hospital’s neonatal intensive care unit

• Regulatory hurdles – what stands in the way of the use of probiotics in America’s high-risk hospital population

Thomas Tompkins

Thomas has beenResearch Director atLallemand since 1999where he has establisheda strong scientific programto evaluate the pre-clinical and clinicaleffects of probiotics. His internal researchteams evaluate the safety and action ofprobiotics and their effect on immunity inhuman cell systems, and novel in vivomodels. His current focus is the role ofthe microbiota, and its associatedresistome, in gastrointestinal andneurological disorders. In particular, he isinterested in identifying the impact ofprobiotics in modulating the functionalityof the brain-gut-microbiome axis. Hecollaborates with a number of externalinvestigators to evaluate the clinicalopportunities for the use of microbes inthe alleviation of symptoms associatedwith gastrointestinal and other mucosa-related disorders.

Clinical studies with probiotics and the brain-gut-microbiota axis: Whathave we have learned after 15+ years?Dr Thomas Tompkins, Research Director, Lallemand Health Solutions.

Thomas’s synopsis is under development. For the latest information please visitwww.probiotaamericas.com/speakers

AGENDADay 2: Thursday June 8

8 IPA WORLD CONGRESS + PROBIOTA AMERICAS

Jürgen Schrezenmeir

Jürgen received his MDfrom the University ofWürzburg andcompleted his habilitationthesis on dietary fiber at theGutenberg University Mainz. His primarycareer focus has been on internalmedicine, gastroenterology,endocrinology and diabetology andnutritional medicine. He led the Instituteof Physiology and Biochemistry ofNutrition of the MRI and has won severalscientific awards. Presently he works forthe Clinical Research Center Kiel.

Probiotic lactobacilli – effects on vaginal microbiota and bacterialvaginosisDr Jürgen Schrezenmeir, Professor of Internal Medicine at the Johannes-Gutenberg-University

The normal vaginal milieu of adult women is maintained by the vaginal microbiotapredominantly consisting of lactobacilli. Bacterial vaginosis (BV), the most commonmicrobiological disorder of the vaginal environment in adult women, is characterized by animbalance of vaginal microbiota: a depletion of lactobacilli (particularly of L. crispatus and L.jensenii) in favour of a wide overgrowth of the vaginal epithelium with a high diversity ofanaerobic bacteria. It is associated with increased risk for ascending urogenital infections andabortion. Although antibiotic treatment of BV is recommended, therapy is still a matter ofdebate. This presentation reviews the current rationale and evidence for the use of oralprobiotics for maintaining normal vaginal microbiota and for managing BV.

• Normal vaginal microbiota versus dysbiosis/BV • Effect of oral probiotics on vaginal microbiota in healthy women • Effect of oral probiotics on BV, its recurrence and on gestational complications

Chairman’s closing remarks

San Francisco bay cruise and dinner

Join us for a relaxing dinner and enjoy views of San Francisco bay at sunset. We’ll cruise pastthe famous PIER 39 sea lions and along the city’s historic waterfront to discover its fascinatingskyline. We’ll take in the Golden Gate Bridge, Sausalito, Angel Island, move past Alcatraz,under the Bay Bridge and pass the AT&T Ball Park before heading down Embarcadero andreturn to PIER 39 where our cruise will end.

But the evening doesn’t have to end there. With 100+ restaurants, shops and attractions, pluslive daily entertainment there’s plenty more to explore at PIER 39, who coincidentally turns 39 this year. For a sneak peek and bit of fun check out the sea lion webcam www.pier39.com/the-sea-lion-story/sea-lion-webcam

Chris Callewaert

Chris received his PhDfrom Ghent University inBelgium. He is now apostdoctoral researchfellow in the Knight lab atthe University of California, San Diego.He investigates body odor and thecharacteristics of the bacteria living in thearmpits, skin, clothes, washing machinesand homes. He is the first to undertakebacterial transplants to solve underarmbody odour.

Beyond the gut.Underarm body odor and a bacterial treatment to solve itDr Chris Callewaert, Department of Pediatrics, School of Medicine, University of California San Diego

Underarm body odor induces strong psychological and social discomforts . The axillarymicrobiome of 189 suffers has been analysed in relation to the odour and psychological impact.It was found that body odor formation was largely determined by the microbiome and is stronglylinked to phylogeny. Nutrition, gender, body mass index, age and shaving also have an impact.Bacterial transplants were carried out on 18 patients, where the malodoros microbiome wasreplaced by a non-odoros microbiome of a family member. Immediate improvements in axillaryhedonic value were seen, and a shift to staphylococcus dominance was evident within onemonth of treatment.

• The influences and psychological impact of underarm body odor• Why underarm body odor is an underrated and taboo disease• Why conventional deodorants and antiperspirants are not the solution• A new bacterial solution,tested and verified, that can lead to next-generation deodorants

9IPA WORLD CONGRESS + PROBIOTA AMERICAS

AGENDADay 3: Friday June 9

Dan Merenstein

Dan is an AssociateProfessor of FamilyMedicine atGeorgetown University,where he also directs FamilyMedicine research. The primary goal ofDan’s research is to provide answers tocommon clinical questions that lackevidence and improve patient care. Danis a clinical trialist who has recruited over1,700 participants for eight probiotictrials since 2006. He has been funded bythe NIH, USDA, Foundations andIndustry. He is an expert on probiotics,antibiotic stewardship in outpatientsettings and also conducts HIV researchin a large women’s cohort.

Lessons learned from Bayer: The impact on companies, providers and patientsDr Dan Merenstein, Associate Professor of Family Medicine, Georgetown University

Research into probiotics and the consumption of probiotics has exploded in the last few years.Unfortunately research, regulatory laws and usage are not synchronized. The U.S. governmentbelieved that the Bayer Corporation did not have data to support a probiotic and brought a caseagainst the company. There are many lessons to be learned from this case, from thegovernment’s approach, that of Bayer’s lawyers and the final verdict. Additionally, as newknowledge has been gained about probiotics, there are questions about when species data isenough to provide evidence of efficacy.

We’ll discuss• The government’s case• The government’s regulations • The verdict• Implications of species vs strain and what that means for companies moving forward

Chairman's re-cap of Day 2 and welcome back

Scientific Frontiers sessionThe authors of our highest rated Scientific Frontiers abstracts – selected by our Scientific

Committee – present key findings and impacts of their research.

2.30 pm Departures

1.15 pm Networking lunch

Closing remarks and look to the futureDr Stephen Daniells, NutraIngredients-USA and George Paraskevakos, International Probiotics Association

Extending consumer markets with new formulations – a success storySpeaker to be announced

New formulations and delivery mechanisms promise to extend market opportunities byappealing to new consumer segments. We take an indepth look at one successful innovator tounderstand the technical and marketing challenges they faced – and how they overcame them.

Panel discussion – next-generation analytical toolsPanelists: • Buffy Stahl, Global Business Development Leader – Probiotics, DuPont Nutrition and

Health. • Prof David Mills, Peter J. Shields Endowed Chair in Dairy Food Science, UC Davis

Buffy Stahl

David Mills

Program is subject to change. For latest updates please visit www.probiotaamericas.com/program

Secure your place

Register online at www.probiotaamericas.com/registerInquiries please email Claudia Rhynes claudia.rhynes@wrbm.com

IPA members: Members of theInternational Probiotics Associationbenefit from a 25% discount – simplyuse the IPA promotional code whenregistering.

Groups or teams: Save 20% whenyou register two or more at the same time. Use promocode GROUP2017 when registering.

Scientific Frontiers participants: If your abstract isaccepted you’ll receive a promotional code entitling youto a 50% discount. Simply enter the code when registeringonline.

Please note: Discounts cannot be combined. If you qualify for more than one

discount we will apply the higher discount rate. Discounts must be redeemed at

time of registration and cannot be applied retroactively.

Our venue

This year’s IPA World Congress + Probiota Americas conference takes place in San Francisco at the premier Hotel Nikko,close to Union Square and at the heart of the city.

For more information and to make a reservation, please go to www.probiotaamericas.com/accommodation

10 IPA WORLD CONGRESS + PROBIOTA AMERICAS

PA World Congress + Probiota Americas rates arestraightforward and registration gives you access tothe full program, including:

• First Focus workshop

• All presentations, panels, roundtable discussionsand business networking sessions

• Welcome reception

• A cruise and dinner on evening of day 2

• Networking lunches

Industry rate: $1,865Academic rate*: $995

* To qualify for the academic rate you must be able to demonstrate that you are

working for an academic institution in a related field.

O’FARRELL STREETO’FARRELL STREET

GEARY STREET

GEARY STREET

GEARY BOULEVARD

POST STREETPOST STREET

POST STREET

ELLIS STREET

ELLIS STREET

ELLIS STREET

O’FARRELL STREET

MASO

N STREET

TAYLOR STRTTE

MASO

N STREET

MASO

N STREET

CYRIL MAG

NIN

STCYRIL M

AGN

IN ST

ELWO

OD

ST

POW

ELL STREET

POW

ELL STREET

STOCKTO

N STREET

STOCKTO

N STREET

UNION SQUARE

HOTELNIKKO

OUR SPONSORS

Through its Nutrition & Health business, DuPont addresses theworld’s challenges in food by offering a wide range ofsustainable, bio-based ingredients and solutions to providesafer, healthier and more nutritious food. Through closecollaboration with customers, DuPont combines knowledge andexperience with a passion for innovation to deliver unparalleledcustomer value to the marketplace.

The global network of food scientists and technologists in DuPont brings world-class expertise to soyproteins, emulsifiers, enzymes, hydrocolloids, cultures, antioxidants, antimicrobials, and an array of health-promoting ingredients to what we call ‘the Global Collaboratory™ - a place where solutions that make areal difference are discovered and brought to life.

Our probiotic cultures are scientifically proven to help keep the digestive system running smoothly and tosupport the body’s immune system. They give you the opportunity to add documented health benefits toyour dairy products, beverages, confectionery and frozen desserts.

www.food.dupont.com

Lallemand Health Solutions (LHS) consolidates the internationallyrecognized probiotic manufacturers Institute Rosell andHarmonium International. Backed by a rich history and 80 yearsof expertise in probiotic research and development, LallemandHealth Solutions offers a full line of ready-to-market probioticformulas and helps its partners to design their own custom &complex formulations using Harmonium, Lafti® or Rosell®Probiotic strains together with our proprietary protective

technologies. Because, from the lab to the shelf, LHS controls the overall manufacturing process of itsproducts, the company can ensure customers are receiving the highest quality standard of probioticformulation.

Cooperation spells success: we provide our partners with the full support they need to develop, register,and market their products in their own market, making Lallemand Health Solutions a complete probioticsolutions provider.

With over 450 formulas marketed in more than 60 countries, our teams are able to fully meet your needs inprobiotics.

www.lallemand-health-solutions.com

Probi is a world leader within probiotics – dedicated to probiotics only. Our vision is to contribute to healthier life by delivering effective and well-documented probiotics, with proven health benefits based on scientificresearch. Probi offers probiotic expertise and partnership all the way fromR&D to finished products for companies within the consumer healthcare andfood industry. Our GMP certified manufacturing facilities produce proven andeffective probiotics in custom-made formats with value-adding deliverytechnologies.

Founded by scientists in Sweden 1991, Probi is a multinational company withfour centers of excellence, active in more than 40 markets around the worldand holding over 400 patents worldwide.

www.probi.se

Diamond Sponsors

11IPA WORLD CONGRESS + PROBIOTA AMERICAS

12 IPA WORLD CONGRESS + PROBIOTA AMERICAS

OUR SPONSORS

AB-BIOTICS is a research company focused on the development ofinnovative solutions based on probiotic and microbiome technologies.Located in Barcelona, AB-BIOTICS started its probiotics research program12 years ago, setting its own collection of more than 1,000 globallysourced strains. Applying the classic pharma development model we leadwith an innovative portfolio of well-documented and specific probioticsproducts for target conditions. AB-BIOTICS offers pharma qualityproducts manufactured under GMP certified manufacturing facilities in

line with strictest regulatory standards. The pipeline includes a range of proprietary supplements designedto improve health in specific health conditions.

AB-BIOTICS is present through local partners in more than 40 markets, selling nine products, covered bymore than 200 patents worldwide.

AB-BIOTICS has the vision that in the future the microbiome will become a relevant part of many diseasestreatment. For that reason we have also developed a pharmacogenomics platform to be able to match thehuman genome with the microbiome, to identify therapeutic needs. AB-BIOTICS is already active in thediagnostics business.

www.ab-biotics.com

Bifodan A/S develops and manufactures probiotic turnkey solutions forB2B customers worldwide. Based just north of Copenhagen, Denmark,Bifodan delivers clinically documented, high quality probiotic products,manufactured at our GMP approved production facility. Bifodan has along history in probiotic bacteria, as the company was founded by the

first Danish dairy to isolate the lactobacillus acidophilus bacteria in 1938.

Bifodan has been dedicated to research and development of probiotic nutritional supplements for threedecades. Our extensive competencies in understanding, formulating and handling probiotic bacteria,allow Bifodan to offer innovative solutions addressing common health issues.Our YourBrand portfolio offers ready to market products in four health areas and is available in NorthAmerica through Bifodan Inc., Boston, MA.

www.bifodan.com

Platinum Sponsors

Jarrow Formulas, Inc. (JFI) is a nutritional supplement manufacturer that marketsits products in the United States and internationally to more than 20 countriesthroughout Europe, Asia, Latin America and the Middle East. The company’sgoal is to promote optimal health with high quality, effective, affordable and“cutting edge” formulations, which are based on sound scientific research data.JFI offers a complete line of nutritional products that includes vitamins, minerals,

standardized herbal concentrates, enzymes and amino acids as well as patented and clinically provenspecialty antioxidant, probiotic and functional food formulations. JFI’s products are manufactured byJarrow Industries Incorporated (GMP certified), a pharmaceutical quality facility located in Santa FeSprings, California.

Jarrow Formulas’ professional staff are also actively involved in clinical studies and in working withresearchers from universities, institutes and other academic environments around the world. JFI fundsresearch studies on many of our products such as bone formulas (Bone-Up®), Co-Q10, lignans, silicon(JarroSil®), pomegranate, probiotics, Alpha Lipoic Acid, and sulforaphane (from broccoli seed extract), inorder to ensure that customers receive the full biological value of these products. JFI strives to providethe best service and technical support to its customers.

www.jarrow.com

13IPA WORLD CONGRESS + PROBIOTA AMERICAS

OUR SPONSORS

Morinaga Milk is one of the largest dairy product manufacturers in Japan and is amarket leader with many top brands in yogurt, milk, infant formula, beverage,cheese, butter, ice cream, pudding, dietary supplements and clinical foods.Founded in 1917, Morinaga Milk exhibits excellence in the field of technologyand sells not only dairy products but also beneficial functional ingredients such asprobiotics, especially Bifidobacteria, such as Bifidobacterium longum BB536 and

Bifidobacterium breve M-16V, which naturally reside in human intestine. Morinaga’s flagship product B.longum BB536 is backed up by more than 130 scientific studies, and its extensive research and provensafety is backed up by FDA GRAS. Morinaga’s probiotics are manufactured in HACCP-certified facilitiesand have been sold in over 30 countries for more than 40 years for use in various applications such asnutritional supplements, infant formulas and dairy products.

www.morinagamilk.co.jp

Prenexus Health is a natural prebiotic ingredient company in the USfocused on individual health and wellness through the research,development, and production of branded natural prebioticingredients for nutrition.

As a science-based company that focuses on digestive health as a foundation for overall health andwellness, enhancing the ‘gut/brain’ axis, Prenexus Health will be an innovative global leader in prebioticssupported by scientific and clinical research that demonstrates their health benefits. We believe inunderstanding digestive health and that helping establish, enrich and protect a healthy gut microbiota isthe single largest opportunity to influence the overall foundation for life long health and wellness.

Our mission is to improve health & wellness of individuals, with a high quality, high purity natural prebioticingredient grown and processed in the US following sustainable environmental practices.

Our novel highly purified ingredient, XOS95™ Prebiotic, can be used in functional foods, beverages andsupplements to offer health benefits for the consumer.

www.prenexushealth.com.

Platinum Sponsors

Probiotical was founded in 1985 and originates from ALCEMicrobiologic Laboratory, Italian leader in the production of lactic acidbacteria for the dairy industry for more than 60 years. It is the first plantworldwide designed exclusively for the research, development andproduction of probiotic micro-organisms.

With core businesses in Europe and developing businesses in Australia, North America, and Asia,Probiotical is the partner of choice for companies seeking high-quality, custom tailored probiotic and/or synbiotic products: safe, effective and stable. The companyoffers a broad portfolio of allergen free, freeze dried or micro-encapsulated, probiotic strains at different concentrations supported by characterization and clinicalstudies. In addition to the production and commercialization of bulk ingredients, special attention isfocused on the development and realization of probiotic and synbiotic finished products with guaranteedefficacy for the duration of their shelf-life.www.probiotical.com

Pharmachem Laboratories, Inc. is a premier international innovator, manufacturer and supplier of the finestquality ingredients. We deliver optimal solutions tailored to meet your needs across a complex matrix ofindustries including nutritionals, food and beverages, flavors and fragrances.

From manufacturing standardized extracts and custom ingredients to developing original solutions forprocess problems, Pharmachem’s sophisticated technologies offer unique options for our customers;extraordinary ingredients, original solutions, impeccable service … always at Pharmachem.www.pharmachemlabs.com

14 IPA WORLD CONGRESS + PROBIOTA AMERICAS

OUR SPONSORS

AIDP Inc. is a leader in functionalingredients with access to the newestsolutions for healthy aging and formulationchallenges. With our vast resources, AIDP is

ahead of the curve in identifying new product segments anddeveloping proven compounds to address formulatingchallenges. We start the domino effect by having some of themost innovative, freshest ideas in the lab, which makes you happyand makes your customers notice.

For 20 years, AIDP has provided quality ingredients to the healthand functional food & beverage industries. In the last 10 years,AIDP developed an expertise providing meaningful, researchbased healthy ageing products. We search for safe products witha competitive advantage.

AIDP has strong connections with factories and formulatorsaround the world. With a newly developed lab and a PhDresearch staff, we can develop cost effective, proprietary solutionsto meet your needs.

www.aidp.com

Gold Sponsors

BioCaps®, is a world leading empty hardcapsule manufacturer in the nutraceuticaland pharmaceutical industries, for morethan four decades, we have been well

recognized as a company dedicated to the highest quality in theindustry. BioCaps offers Gelatin, Hypromellose (HPMC) and AcidResistant capsules with a variety of sizes and color choices.

Biocaps’s Acid Resistant Capsule is an ultimate solution to protectacid-sensitive ingredients from stomach acid; it dissolves quicklyin neutral media and is a perfect choice for Probiotic and Enzymeformulations without a heavy investment on dosage like anenteric coated process. The capsule also has received a USPatent.

Biocaps offers a pro-active tech support service for all itscustomers’ capsule needs. We also offer extensive training for ourcustomers on all types of capsule filling machines to increaseproduction yield and reduce cost.

www.biocaps.net

Capsugel is a global leader in deliveringhigh-quality, innovative dosage forms andsolutions to its customers in the health care

industry. The company’s Hard Capsule business unit offerscustomers the broadest portfolio of gelatin, vegetarian, and otherspecialized capsule technologies. Capsugel’s Dosage FormSolutions business unit utilizes an array of proprietarytechnologies and specialized manufacturing capabilities to solvecustomers’ most pressing product development challenges,including bioavailability enhancement, modified release, abusedeterrence, biotherapeutic processing, and inhalationformulation. The company’s fast-to-clinic program streamlinesproduct development from pre-formulation through clinical andcommercial supply for finished dosage forms. Headquartered inMorristown, N.J., Capsugel serves more than 4,000 customers inmore than 100 countries.

www.capsugel.com

Founded in 1988, Sabinsa is amanufacturer and supplier of herbalextracts, cosmeceuticals, mineralsand specialty fine chemicals

including Lactospore™. Our mission is to provide alternative andcomplementary natural products for human nutrition and well-being. We have successfully brought to market more than 100standardized botanical extracts and privately funded severalclinical studies in conjunction with prestigious institutions insupport of these products. We employ 1,000 people worldwidein ten manufacturing, R&D and distribution facilities. Productsintended for human consumption are certified Kosher and Halal.With more than 120 scientists working full time conductingongoing research, Sabinsa develops and patents beneficialnutrients for the world market.

Our mission is to be a responsible biotechnology-based research,manufacturing and marketing company supplying the finest rawmaterials to the dietary supplement, cosmetic, speciality chemicaland pharmaceutical industries. We currently hold over 130 USAand International patents, and have 100 pending patentapplications worldwide.

www.sabinsa.com

15IPA WORLD CONGRESS + PROBIOTA AMERICAS

OUR SPONSORS

Gold Sponsors

Exhibitors

Novanat (also known as Jiao DaOnlly Group) was the firstpublicly listed healthcarecompany in China and has

researched and produced probiotics since 1990. Novanatspecializes in providing high cell density single probiotic strains,probiotic premix, formulation advice and the manufacturing ofprobiotic tablets, capsules and sachets.

Novanat’s probiotic strains are unique because our culturecollection holds over 500 specific and generic probiotic strainsincluding Lactobacillus, Bifidobacterium, Streptococcus andEnterococcus; our manufacturing optimization ensures excellentstability and high cell density strains; and strict quality controlguarantees the pure quality. Novanat operates within currentGMP facilities, ISO, KOSHER and HACCP systems. A new factoryis planned to increase probiotics supply.

www.novanat.com

Reasearch & Manufacturing of Probiotics since 1990

Vitalus Nutrition is a leadingproducer and supplier ofspeciality dairy ingredients. At ourfacility in Abbotsford BC, we

produce specialized milk protein concentrates, isolates and otherhigh-value technical milk ingredients. With the launch of ournewest product scheduled for launch in late 2017, we will be oneof the first North American producers of galacto-oligosaccharides(VITAGOS™), a key ingredient in various adult and infant nutritionproducts.

We have built our success by developing meaningful long-termcustomer relationships and contributing to our customers’success, while nurturing a very strong and united corporateculture.

www.vitalus.com

Since 1979, UAS Labs hasmanufactured premium probiotics inthe United States. It’s all they do andall they’ve ever done. Our pursuit of

probiotic perfection has led us to continually invest in research,the latest technology, a state-of-the-art manufacturing facility andan expert team of probiotic professionals.

UAS Labs leverages over 50 years of experience in probioticformulation and marketing to provide customers with probioticsthey can count on. Our experienced staff includes PhD’s,pharmacists, microbiologists, biochemists, and food scientistswho have all dedicated their lives to probiotic research anddevelopment. This unwavering commitment to probioticstranslates into UAS Labs having one of the few probiotic-onlymanufacturing facilities in the United States. This GMP certifiedfacility is designed with culture stability in mind and boastshumidity and temperature controlled rooms that stabilized foroptimal probiotic production.

UAS is fully integrated from formulation through manufacturing,packaging, and marketing and adheres to the highest qualitystandards. UAS has made significant investments to research,streamlining operations through new technology and innovations,and ultimately introducing new products. These investmentsallow UAS to offer reasonable MOQ’s and industry leading leadtimes that are sure to fit any schedule.

www.uaslabs.com

Interested in becoming a sponsor or exhibitor? Limited opportunities available. Please contact: tim.evans@wrbm.com

With more than 273,000independently audited uniquevisitors per month,NutraIngredients-USA.com andNutraIngredients.com are theindispensable as-it-happens news sources for thefunctional foods and supplements industries.

Using dynamic audio, visual and text formats, NutraIngredients.comjournalists offer the expertise required to unpick, process and effectivelycommunicate the scientific, regulatory and industry issues that matter to yourorganization.

Whether it is a dispatch from the frontier of probiotic science, the latest healthclaim developments or in-depth new ingredient appraisal,NutraIngredients.com brings you the news first.

www.NutraIngredients-USA.com

The International Probiotics Association (IPA) is aninternational organization with members equally dividedbetween industry and academia. Its goal is to provide a unique forum for the exchange of research and the latestbreakthroughs in probiotic technology and new productdevelopment. The IPA holds NGO status before CodexAlimentarius and is the global voice of probiotics as most of theworld’s industrial producers are members.

Brought to you by

Organized by

The IPA World Congress + Probiota Americasevent series is organized by Vision Events, a division

of William Reed Business Media, the publishers ofNutraIngredients, FoodNavigator and a host of digital

newsletters, publications and data sources for the food,drink and nutrition industries.

As an international multi-media events company, we welcomemore than 40,000 delegates to over 40 live events, conferences

and exhibitions every year – on every continent. We’re the namebehind some of the industry’s most influential global award

programs including the International Wine Challenge and theWorld’s Best Restaurants. We regularly engage with over

2.8 million food, drink and nutrition professionals.

www.probiotaamericas.com